Heart rate variability changes by non-invasive ventilation in obesity hypoventilation syndrome.
bi-level positive airway pressure (BiPAP)
heart rate variability (HRV)
non-invasive positive pressure ventilation (NIPPV)
obesity hypoventilation syndrome (OHS)
Journal
The clinical respiratory journal
ISSN: 1752-699X
Titre abrégé: Clin Respir J
Pays: England
ID NLM: 101315570
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
17
01
2020
accepted:
10
03
2021
pubmed:
17
3
2021
medline:
19
8
2021
entrez:
16
3
2021
Statut:
ppublish
Résumé
Non-invasive positive pressure ventilation (NIPPV) is known to enhance hypoventilation and is particularly adopted as a treatment for patients diagnosed with obesity hypoventilation syndrome (OHS). The augmented risk of cardiovascular morbidity is known as a side effect of OHS. In this paper, this inference is examined that hypoventilation and the increased risk of morbidity can be diagnosed via the assessment of changes in heart rate variability (HRV). More specifically, the study investigates the effect of NIPPV on both HRV and hypoventilation among OHS patients. The linear relationship between different HRV measures and ventilation parameters is also examined. The reported results are attained via an interventional clinical trial study. HRV measures are evaluated before and after treatment, in a group of patients which are newly diagnosed with OHS and receive bi-level positive airway pressure (BiPAP) treatment for three months. The results are compared and interpreted via statistical analysis. Throughout the study, the relationship between hypoventilation and HRV is confirmed, as well as the effect of BiPAP on some HRV measures in both time and frequency domains. Particularly significant connections are observed between hypoventilation and low-frequency components of HRV. The enhanced respiration due to the application of BiPAP can improve the performance of autonomous nervous and cardiovascular systems, in terms of HRV. Moreover, it is suggested to consider some HRV parameters to control the cardiovascular side-effects of OHS and confine the resulting mortality rate in long term.
Sections du résumé
BACKGROUND
BACKGROUND
Non-invasive positive pressure ventilation (NIPPV) is known to enhance hypoventilation and is particularly adopted as a treatment for patients diagnosed with obesity hypoventilation syndrome (OHS). The augmented risk of cardiovascular morbidity is known as a side effect of OHS.
AIMS
OBJECTIVE
In this paper, this inference is examined that hypoventilation and the increased risk of morbidity can be diagnosed via the assessment of changes in heart rate variability (HRV). More specifically, the study investigates the effect of NIPPV on both HRV and hypoventilation among OHS patients. The linear relationship between different HRV measures and ventilation parameters is also examined.
MATERIALS & METHODS
METHODS
The reported results are attained via an interventional clinical trial study. HRV measures are evaluated before and after treatment, in a group of patients which are newly diagnosed with OHS and receive bi-level positive airway pressure (BiPAP) treatment for three months.
RESULTS
RESULTS
The results are compared and interpreted via statistical analysis.
DISCUSSION
CONCLUSIONS
Throughout the study, the relationship between hypoventilation and HRV is confirmed, as well as the effect of BiPAP on some HRV measures in both time and frequency domains. Particularly significant connections are observed between hypoventilation and low-frequency components of HRV.
CONCLUSION
CONCLUSIONS
The enhanced respiration due to the application of BiPAP can improve the performance of autonomous nervous and cardiovascular systems, in terms of HRV. Moreover, it is suggested to consider some HRV parameters to control the cardiovascular side-effects of OHS and confine the resulting mortality rate in long term.
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
770-778Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
Camm AJ, Malik M, Bigger J, et al. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J. 1996;17(3):354-381.
Shields RW. Heart rate variability with deep breathing as a clinical test of cardiovagal function. Cleve Clin J Med. 2009;76(Suppl 2):S37-S40.
Pumprla J, Howorka K, Groves D, Chester M, Nolan J. Functional assessment of heart rate variability: physiological basis and practical applications. Int J Cardiol. 2002;84(1):1-14.
Borel JC, Borel AL, Monneret D, Tamisier R, Levy P, Pepin JL. Obesity hypoventilation syndrome: from sleep-disordered breathing to systemic comorbidities and the need to offer combined treatment strategies. Respirology. 2012;17(4):601-610.
Olson AL, Zwillich C. The obesity hypoventilation syndrome. Am J Med. 2005;118(9):948-956.
Kim HJ, Hong S, Han JK, et al. A case of severe obesity-hypoventilation syndrome treated by bilevel positive airway pressure therapy. J Korean Neurol Assoc. 2005;23(6):836-839.
Serrano V, Gavela J, Gavari P, et al. Pulmonary gas exchange during mechanical non invasive ventilation in acute hypercapnic patients with obesity hypoventilation syndrome (OHS). 2011;38(Suppl 55):3793.
La Rovere MT, Pinna GD, Maestri R, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation. 2003;107(4):565-570.
Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the united kingdom heart failure evaluation and assessment of risk trial (uk-heart). Circulation. 1998;98(15):1510-1516.
Fioranelli M, Piccoli M, Mileto G, et al. Analysis of heart rate variability five minutes before the onset of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 1999;22(5):743-749.
Smilde TD, van Veldhuisen DJ, van den Berg MP. Prognostic value of heart rate variability and ventricular arrhythmias during 13-year follow-up in patients with mild to moderate heart failure. Clin Res Cardiol. 2009;98(4):233-239.
Villareal RP, Liu BC, Massumi A. Heart rate variability and cardiovascular mortality. Curr Atheroscler Rep. 2002;4(2):120-127.
Tripathi K. Respiration and heart rate variability: a review with special reference to its application in aerospace medicine. Indian J Aerosp Med. 2004;48(1):64-75.
Pöyhönen M, Syväoja S, Hartikainen J, Ruokonen E, Takala J. The effect of carbon dioxide, respiratory rate and tidal volume on human heart rate variability. Acta Anaesthesiol Scand. 2004;48(1):93-101.
Altuncu ME, Baspinar O, Keskin M. The use of short-term analysis of heart rate variability to assess autonomic function in obese children and its relationship with metabolic syndrome. Cardiology J. 2012;19(5):501-506.
Zahorska-Markiewicz B, Kuagowska E, Kucio C, Klin M. Heart rate variability in obesity. Int J Obes Relat Metabol Disord. 1993;17(1):21-23.
Koenig J, Jarczok M, Warth M, et al. Body mass index is related to autonomic nervous system activity as measured by heart rate variability-a replication using short term measurements. J Nutr, Health Aging. 2014;18(3):300-302.
Rabbia F, Silke B, Conterno A, et al. Assessment of cardiac autonomic modulation during adolescent obesity. Obesity. 2003;11(4):541-548.
Piper AJ, Wang D, Yee BJ, Barnes DJ, Grunstein RR. Randomised trial of cpap vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax. 2008;63(5):395-401.
Borel J-C, Tamisier R, Gonzalez-Bermejo J, et al. Noninvasive ventilation in mild obesity hypoventilation syndrome: a randomized controlled trial. Chest. 2012;141(3):692-702.
Budweiser S, Riedl S, Jörres R, Heinemann F, Pfeifer M. Mortality and prognostic factors in patients with obesity-hypoventilation syndrome undergoing noninvasive ventilation. J Intern Med. 2007;261(4):375-383.
Priou P, Hamel J-F, Person C, et al. Long-term outcome of noninvasive positive pressure ventilation for obesity hypoventilation syndrome. Chest. 2010;138(1):84-90.
Singer DH, Martin GJ, Magid N, et al. Low heart rate variability and sudden cardiac death. J Electrocardiol. 1988;21:S46-S55.
Task Force of the European Society of Cardiology. Heart rate variability, standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93:1043-1065.
Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Front Public Health. 2017;5:258. https://doi.org/10.3389/fpubh.2017.00258